JPRN-UMIN000046096尚未招募未知
ationwide Survey of Aggressive NK-cell leukemia: multi-center retrospective study in Japan - ANKL22
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case which diagnosis is not matched with the diagnostic criteria of aggressive NK-cell leukemia suggested in WHO classification /Case which is withdrawn to register this study
研究者
相似试验
尚未招募
2 期
Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell LymphomaNK-T-Cell Lymphoma, ExtranodalNCT05774028The First Affiliated Hospital with Nanjing Medical University50
进行中（未招募）
不适用
AML19 PilotEUCTR2013-000501-22-GBCardiff Univeristy153
已完成
不适用
atural Killer (NK) Cell Therapy Combined with Hepatic Artery Infusion Chemotherapy (HAIC) in Patients with Advanced Hepatocellular CarcinomaNeoplasmsKCT0004642Vaxcell-Bio20
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.JPRN-jRCTc030190255Goto Shigenori6,000
已完成
不适用
MRC ALL 97 - UK national lymphoblastic leukaemia (ALL) trialeukaemiaLymphoblastic leukaemiaCancerISRCTN26727615Medical Research Council (MRC) (UK)1,800